AnnouncementsDishman Pharma appoints Rajashekhar Bhat as Global CFO
AnnouncementsDishman Pharma appoints Tushar Shah as company secretary
AnnouncementsDishman Pharma clarifies on news item
No recommendations so far.What's your call on Dishman Pharma today? Read Investor view
|Company Name||Last Price||%
|Dr Reddys Labs||2556.00||0.66||2939.80||1904.15||43,479.83|
|Dec' 13||Sep' 13||Jun' 13||Mar' 13|
|No Mutual Funds Holding the share|
Dishman Pharma is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 713.77 crore.The company has reported a consolidated sales of Rs 313.42 crore and a Net Profit of Rs 15.16 crore for the quarter ended Dec 2013.
The company management includes Janmejay R Vyas - Chairman & Managing Director, Deohooti J Vyas - Whole Time Director, Arpit J Vyas - Whole Time Director, Yagneshkumar B Desai - Director, Sanjay S Majmudar - Director, Ashok C Gandhi - Director.
It is listed on the BSE with a BSE Code of 532526 and the NSE with an NSE Code of DISHMAN.
Its Registered office is at Bhadr - Raj Chambers, Swastik Cross Road,,Navrangpura. Ahmedabad,Gujarat - 380009.
Their Registrars are Link Intime India Pvt. Ltd.